TINEARITY

LIVE

Serial Number

79372513

Owner

Circius Pharma AB

Attorney

John Pickerill

Filing Date

Apr 12, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

TINEARITY Trademark

Serial Number: 79372513 • Registration: 7885426

TINEARITY is a trademark filed by Circius Pharma AB on April 12, 2023. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Trademark Classes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

Circius Pharma AB (5 trademarks)

Södra Långebergsgatan 34-36

Entity Type: 16

Duearity AB (3 trademarks)

Stillmansgatan 12

Entity Type: 64

Legal Representation

Attorney of Record

John Pickerill

5,819 trademarks filed View all →

Correspondence Address

John Pickerill Fredrikson & Byron, P.A.

600 South 6th Street, Suite 1500

Minneapolis, MN 55402

United States

Trademark Details

Filing Date

April 12, 2023

Registration Date

August 12, 2025

Published for Opposition

June 24, 2025

Goods & Services

Medical device for relieving tinnitus; Medical device that can be adapted to the head shape of individuals and which is placed behind the ear in the form of a transmission box that transmits sound via the skull for use in treating or relieving tinnitus; Medical device that emits sound for use in treating or relieving tinnitus; Medical device that emits white noise for use in treating or relieving tinnitus; Medical electronic apparatus namely medical hearing instruments and parts of such devices; Medical apparatus and instruments for monitoring tinnitus

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB

Mar 5, 2026 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Feb 18, 2026 FICS

FINAL DISPOSITION PROCESSED

Feb 17, 2026 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Nov 12, 2025 FICR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 12, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Aug 12, 2025 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 24, 2025 NPUB

PUBLISHED FOR OPPOSITION

Jun 24, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 18, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 21, 2025 CNSA

CHANGE OF OWNER RECEIVED FROM IB

Apr 24, 2025 CHLD

ASSIGNED TO EXAMINER

Apr 24, 2025 DOCK

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Dec 7, 2024 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Nov 20, 2024 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Nov 20, 2024 OPNR

ASSIGNED TO EXAMINER

Oct 17, 2024 DOCK

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 23, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 23, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 23, 2024 TROA

REFUSAL PROCESSED BY IB

Mar 18, 2024 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Feb 29, 2024 RFCS

REFUSAL PROCESSED BY MPU

Feb 29, 2024 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Feb 3, 2024 RFCR

NON-FINAL ACTION WRITTEN

Feb 2, 2024 CNRT

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

Jan 29, 2024 RFWR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jan 12, 2024 RFCR

NON-FINAL ACTION WRITTEN

Jan 11, 2024 CNRT

ASSIGNED TO EXAMINER

Jan 9, 2024 DOCK

APPLICATION FILING RECEIPT MAILED

Jun 27, 2023 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 23, 2023 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jun 22, 2023 REPR

Related Trademarks

More from this Owner

OTINOVA

TINEARITY

E DUEARITY

TINEARITY

More in Same Class

GENEXT

RELIMEDPRO